Skip to Content

Option Care stays on ‘offense’

Option Care stays on ‘offense’

John RademacherBANNOCKBURN, Ill. – Option Care Health is moving to open 10 to 15 new standalone infusion suites by year-end, a key part of its growth strategy, CEO John Rademacher said during an Aug. 3 earnings call. 

During the second quarter of 2021, 20% of the company’s nursing visits took place in one of its more than 120 suites – 400 chairs – across the country. 

“Our expectations as we move forward is, we can be pushing that post (by) opening more centers and having more convenient facilities available for the patient population,” he said. “I think that we're looking to push north of that, 23% to 25%.” 

Option Care Health reported net revenue of $860.3 million for the second quarter of 2021, up 16.1% compared to $740.8 million in the second quarter of 2020. 

Across its portfolios, the company saw high, single-digit growth for acute care and high-teens growth for chronic care year-over-year, with particularly strong showings in newer therapies for multiple sclerosis and myasthenia gravis. 

“Over the past few quarters, we've seen referral patterns return to pre-COVID levels, and in some instances, including several chronic therapies, we've seen referrals considerably above pre-COVID levels,” said Rademacher. “The team has remained on offense, so to speak, and we’ve focused on balanced growth across both our acute and chronic portfolios through collaborations with our payer partners and referral sources.” 

While referrals rebounded in the quarter, Option Care is monitoring the rise of COVID cases related to the Delta variant, says Rademacher. 

“We certainly feel the impact as hospitals reset,” he said. “But right now, it's been a pretty short duration for the variant, and we're trying to monitor and manage that very closely.” 


To comment on this post, please log in to your account or set up an account now.